150 related articles for article (PubMed ID: 23239404)
1. Development of a miR-92a delivery system for anti-angiogenesis-based cancer therapy.
Ando H; Okamoto A; Yokota M; Shimizu K; Asai T; Dewa T; Oku N
J Gene Med; 2013 Jan; 15(1):20-7. PubMed ID: 23239404
[TBL] [Abstract][Full Text] [Related]
2. Polycation liposomes as a vector for potential intracellular delivery of microRNA.
Ando H; Okamoto A; Yokota M; Asai T; Dewa T; Oku N
J Gene Med; 2013 Oct; 15(10):375-83. PubMed ID: 24105805
[TBL] [Abstract][Full Text] [Related]
3. Advanced cancer therapy by integrative antitumor actions via systemic administration of miR-499.
Ando H; Asai T; Koide H; Okamoto A; Maeda N; Tomita K; Dewa T; Minamino T; Oku N
J Control Release; 2014 May; 181():32-9. PubMed ID: 24593893
[TBL] [Abstract][Full Text] [Related]
4. Leukemia cell to endothelial cell communication via exosomal miRNAs.
Umezu T; Ohyashiki K; Kuroda M; Ohyashiki JH
Oncogene; 2013 May; 32(22):2747-55. PubMed ID: 22797057
[TBL] [Abstract][Full Text] [Related]
5. High concentrations of uric acid inhibit angiogenesis via regulation of the Krüppel-like factor 2-vascular endothelial growth factor-A axis by miR-92a.
Yu S; Hong Q; Wang Y; Hou K; Wang L; Zhang Y; Fu B; Zhou Y; Zheng W; Chen X; Wu D
Circ J; 2015; 79(11):2487-98. PubMed ID: 26299712
[TBL] [Abstract][Full Text] [Related]
6. Dicetyl phosphate-tetraethylenepentamine-based liposomes for systemic siRNA delivery.
Asai T; Matsushita S; Kenjo E; Tsuzuku T; Yonenaga N; Koide H; Hatanaka K; Dewa T; Nango M; Maeda N; Kikuchi H; Oku N
Bioconjug Chem; 2011 Mar; 22(3):429-35. PubMed ID: 21361311
[TBL] [Abstract][Full Text] [Related]
7. miR-92a regulates angiogenic activity of adipose-derived mesenchymal stromal cells.
Kalinina N; Klink G; Glukhanyuk E; Lopatina T; Efimenko A; Akopyan Z; Tkachuk V
Exp Cell Res; 2015 Nov; 339(1):61-6. PubMed ID: 26477824
[TBL] [Abstract][Full Text] [Related]
8. miR-92a inhibits peritoneal dissemination of ovarian cancer cells by inhibiting integrin α5 expression.
Ohyagi-Hara C; Sawada K; Kamiura S; Tomita Y; Isobe A; Hashimoto K; Kinose Y; Mabuchi S; Hisamatsu T; Takahashi T; Kumasawa K; Nagata S; Morishige K; Lengyel E; Kurachi H; Kimura T
Am J Pathol; 2013 May; 182(5):1876-89. PubMed ID: 23499550
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of miR-7 promotes angiogenesis in human umbilical vein endothelial cells by upregulating VEGF via KLF4.
Li YZ; Wen L; Wei X; Wang QR; Xu LW; Zhang HM; Liu WC
Oncol Rep; 2016 Sep; 36(3):1569-75. PubMed ID: 27431648
[TBL] [Abstract][Full Text] [Related]
10. Hydrogel-mediated delivery of microRNA-92a inhibitor polyplex nanoparticles induces localized angiogenesis.
Radmanesh F; Sadeghi Abandansari H; Ghanian MH; Pahlavan S; Varzideh F; Yakhkeshi S; Alikhani M; Moradi S; Braun T; Baharvand H
Angiogenesis; 2021 Aug; 24(3):657-676. PubMed ID: 33742265
[TBL] [Abstract][Full Text] [Related]
11. Kaposi's sarcoma-associated herpesvirus microRNAs repress breakpoint cluster region protein expression, enhance Rac1 activity, and increase in vitro angiogenesis.
Ramalingam D; Happel C; Ziegelbauer JM
J Virol; 2015 Apr; 89(8):4249-61. PubMed ID: 25631082
[TBL] [Abstract][Full Text] [Related]
12. Liver X receptor-α and miR-130a-3p regulate expression of sphingosine 1-phosphate receptor 2 in human umbilical vein endothelial cells.
Fan A; Wang Q; Yuan Y; Cheng J; Chen L; Guo X; Li Q; Chen B; Huang X; Huang Q
Am J Physiol Cell Physiol; 2016 Feb; 310(3):C216-26. PubMed ID: 26669941
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-92a -mediated endothelial to mesenchymal transition controls vein graft neointimal lesion formation.
Zhong CM; Li S; Wang XW; Chen D; Jiang ZL; Zhang C; He XJ; Huang C; Jiang YJ; Wu QC
Exp Cell Res; 2021 Jan; 398(1):112402. PubMed ID: 33253710
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of PTEN-positive metastatic tumors to small interfering RNA targeting the mammalian target of rapamycin.
Koide H; Asai T; Kato H; Yonenaga N; Yokota M; Ando H; Dewa T; Nango M; Maeda N; Oku N
Nanomedicine; 2015 Jan; 11(1):185-94. PubMed ID: 25240598
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Angiogenesis by Ultrasound-Mediated MicroRNA-126-3p Delivery.
Cao WJ; Rosenblat JD; Roth NC; Kuliszewski MA; Matkar PN; Rudenko D; Liao C; Lee PJ; Leong-Poi H
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2401-11. PubMed ID: 26381870
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of microRNA-92a prevents endothelial dysfunction and atherosclerosis in mice.
Loyer X; Potteaux S; Vion AC; Guérin CL; Boulkroun S; Rautou PE; Ramkhelawon B; Esposito B; Dalloz M; Paul JL; Julia P; Maccario J; Boulanger CM; Mallat Z; Tedgui A
Circ Res; 2014 Jan; 114(3):434-43. PubMed ID: 24255059
[TBL] [Abstract][Full Text] [Related]
17. [Antineovascular gene therapy by Ago2 knockdown].
Hatanaka K; Shimizu K; Asai T; Oku N
Yakugaku Zasshi; 2008 Nov; 128(11):1567-75. PubMed ID: 18981691
[TBL] [Abstract][Full Text] [Related]
18. Extracellular Vesicles Containing MicroRNA-92a-3p Facilitate Partial Endothelial-Mesenchymal Transition and Angiogenesis in Endothelial Cells.
Yamada NO; Heishima K; Akao Y; Senda T
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500278
[TBL] [Abstract][Full Text] [Related]
19. MiR-92a regulates viability and angiogenesis of endothelial cells under oxidative stress.
Zhang L; Zhou M; Qin G; Weintraub NL; Tang Y
Biochem Biophys Res Commun; 2014 Apr; 446(4):952-8. PubMed ID: 24650666
[TBL] [Abstract][Full Text] [Related]
20. Triptolide inhibits angiogenesis in microvascular endothelial cells through regulation of miR-92a.
Xu X; Tian L; Zhang Z
J Physiol Biochem; 2019 Nov; 75(4):573-583. PubMed ID: 31691162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
